David Protein Says ‘Diet’ Trends Are Over, GLP-1s Upend Markets
David Rahal, founder and CEO of David Protein, argues GLP-1 drugs have upended the diet-trend cycle, reshaping how br...
Protecting index funds involves diversification, risk awareness, and appropriate investment choices. This intro highlights core safeguards you should know.
15,769 articlesDavid Rahal, founder and CEO of David Protein, argues GLP-1 drugs have upended the diet-trend cycle, reshaping how br...
A short pause in ETF inflows didn’t last long. The latest move shows bitcoin etfs draw investment back into focus, as...
A notable fund manager recently exited an ETF position in a move that grabbed attention across the investing world. T...
SpaceX IPO chatter has investors itching for early exposure. This guide breaks down the smartest, legally sound ways ...
When a large manager trims a position, questions follow. This article breaks down Hilton Capital’s $25 million GPIX s...
Investors are buzzing about whether strategy's peers will dump Bitcoin in a downturn. Analysts argue that headlines m...
MSTU, a 2x daily ETF linked to MSTR, has endured a brutal period as the underlying stock and crypto markets gyrate, s...
Ripple's private business shows strong growth while XRP trades near a $1 price. This article builds a practical, evid...
Two 2x MicroStrategy ETFs, MSTX and MSTU, are under renewed scrutiny as volatility tests the funds' synthetic exposur...
Bitcoin is testing new support near $60,000 as Strategy Shares hover below the $100 mark. This dual move highlights h...
Regulatory clarity is heating up this summer. As Congress moves forward with the Clarity Act, Ethereum could emerge a...
The tech hand over fist craze can pull even careful investors into hype. This article lays out a practical plan: choo...